Fei Zhou, Shengxiang Ren, Guowei Che, Chen Zhou, Xin Zhao, Jun Zhao, Yanqiu Zhao, Jianchun Duan, Lin Wu, Yongchang Zhang, Chengzhi Zhou, Caicun Zhou. "Vebreltinib plus PLB1004 in EGFR-mutated NSCLC with acquired MET amplification or overexpression after failure on EGFR-TKI treatment: A phase Ib/II study.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.8632